G6PD and breast carcinoma: The consequences of G6PD inhibition, including inhibited cell proliferation, increased oxidative stress, and enhanced glycolytic pathway, were reported in the breast cancer cell line MCF7 [73] and are consistent with our observations reported here and before, i.e., decreased proliferation [9].